Pharmacologic Class Information
|Pharmacologic Name||Glucagon-like Peptide-2 (GLP-2) Agonists|
|Pharmacologic Concept||Mechanisms of Action - [MoA]|
|Pharmacologic Concept Description||This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.|
NDC Products with Glucagon-like Peptide-2 (GLP-2) Agonists
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Glucagon-like Peptide-2 (GLP-2) Agonists [MoA].
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Status|
|68875-0101||Gattex||Non-Proprietary Name: Teduglutide||Injection, Powder, Lyophilized, For Solution||Subcutaneous||Takeda Pharmaceuticals America, Inc.||ACTIVE|